Skip to main content

Table 3 RDSa-adjusted prevalence and bivariate and multivariate logistic regression analyses of factors associated with HBVb HCVc and HTLVd 1&2 infection among men who have sex with men in Ouagadougou

From: Hepatitis B, C, and D virus and human T-cell leukemia virus types 1 and 2 infections and correlates among men who have sex with men in Ouagadougou, Burkina Faso

Variables

n

HBV infection

HCV infection

HTLV1&2 infection

Positive

ORe (95% CIf)

p

AORg (95% CI)

p

Positive

OR (95% CI)

p

AOR (95% CI)

p

Positive

OR (95% CI)

p

AOR (95% CI)

p

Current age (years)

 18–20

78

17.7

1

   

07.3

1

   

3.9

1

   

 20–24

196

19.6

1.13 (0.57–2.23)

0.724

–

 

13.3

1.96 (0.76–5.04)

0.162

2.07 (0.80–5.33)

0.131

4.1

1.05 (0.27–4.10)

0.943

–

–

 25–29

35

23.1

1.14 (0.52–3.75)

0.502

–

 

02.9

0.37 (0.04–3.33)

0.381

–

–

0.0

1

   

 > = 30

20

35.9

2.60 (0.86–7.87)

0.089

0.76 (0.11–4.94)

0.774

16.4

2.50 (0.55–11.20)

0.230

–

–

10.9

3.01 (0.46–19.65)

0.248

–

–

Total

329

20.4

    

11.0

    

4.0

    

Country of birth

 Burkina Faso

272

20.7

1

   

09.9

1

   

4.1

1

   

 Other countries

57

18.8

0.88 (0.42–1.83)

0.742

–

 

16.0

1.73 (0.76–3.94)

0.186

1.88 (0.78–4.50)

0.153

3.6

0.86 (0.18–4.04)

0.853

–

–

Childhood environment

 Urban

288

20.0

1

   

10.8

1

   

4.2

1

   

 Rural

27

32.3

1.91 (0.80–4.51)

0.140

1.46 (0.53–3.98)

0.452

15.1

1.46 (0.47–4.55)

0.504

–

–

3.8

0.88 (0.11–7.17)

0.910

–

–

Highest educational level

 None or primary

25

24.4

1

   

04.1

1

   

4.1

1

   

 Secondary

239

16.2

0.60 (0.22–1.62)

0.319

–

 

11.7

3.11 (0.40–24.17)

0.277

–

–

4.2

1.04 (0.13–8.58)

0.970

–

–

 University

65

34.5

1.58 (0.54–4.57)

0.393

–

 

11.0

2.90 (0.33–25.23)

0.332

–

–

3.1

0.76 (0.06–8.93)

0.830

–

–

Occupation

 Student/pupil

236

17.9

1

   

12.2

1

   

3.8

1

   

 Employed

72

28.4

1.84 (01.0–3.40)

0.051

1.64 (0.60–4.47)

0.331

05.7

0.43 (0.14–1.29)

0.134

0.22 (0.03–1.38)

0.109

2.9

0.73 (0.15–3.51)

0.700

–

–

 Unemployed

21

21.2

1.07 (0.36–3.36)

0.907

  

14.3

1.19 (0.32–4.34)

0.784

  

9.5

(0.52–13.16)

0.238

–

–

Marital status

 Single

310

19.1

1

   

10.9

1

   

3.9

1

   

 Other*

18

42.0

3.03 (1.16–7.86)

0.023

1.44 (0.30–6.80)

0.640

11.3

1.03 (0.22–4.72)

0.964

–

–

5.6

1.79 (0.21–14.88)

0.589

–

–

Number of biological children

 0

305

20.5

1

   

10.5

1

   

4.0

    

 > = 1

24

20.1

0.98 (0.98–2.78)

0.972

–

 

17.6

1.82 (0.58–5.73)

0.299

–

–

4.4

1.11 (0.14–9.04)

0.921

–

–

Sexual orientation

 Gay/homosexual

236

20.1

1

   

10.3

1

   

3.0

1

   

 Bisexual

21

30.5

1.58 (0.57–4.31)

0.370

–

 

19.0

2.05 (0.63–6.64)

0.229

–

–

4.8

1.62 (0.18–13.96)

0.661

3.31 (0.22–47.9)

0.378

 Transgender

72

18.4

0.90 (0.46–1.78)

0.782

–

 

10.8

1.05 (0.44–2.48)

0.904

–

–

7.1

2.47 (0.75–8.11)

0.133

2.29 (0.27–19.0)

0.440

Anal sex position

 Receptive

19

26.9

1

   

10.8

1

   

0.0

    

 Insertive

310

20.1

0.67 (0.23–1.97)

0.477

–

 

11.0

1.02 (0.22–4.65)

0.979

–

–

5.0

–

–

–

–

Past 12 month STI symptoms

 No

311

19.4

I

   

11.3

1

   

2.9

1

   

 Yes

18

37.4

2.47 (0.91–6.73)

0.075

1.03 (0.24–4.32)

0.964

05.7

0.47 (0.06–3.72)

0.478

–

–

22.8

9.76 (2.65–35.89)

0.001

14.19 (2.88–69.8)

0.001

Vaccinated against HBV

 No

264

22.4

1

   

10.2

1

   

3.1

1

   

 Yes

51

15.8

0.65 (0.28–1.46)

0.299

–

 

13.8

1.41 (0.57–3.46)

0.450

–

–

5.9

5.25 (0.50–7.81)

0.324

–

–

 Don’t know

14

1

–

   

14.3

1.46 (0.30–6.95)

0.630

–

–

14.3

5.25 (1.00–27.70)

0.051

2.02 (0.28–14.34)

0.477

Type of sexual partners in the last 12 months

 Only males

201

19.8

1

   

12.9

1

   

2.0

1

   

 Males and females

127

21.5

2.29 (1.22–4.30)

0.010

220 (0.83–5.78)

0.108

07.9

0.57 (0.26–1.25)

0.164

0.98 (0.39–2.40)

0.977

6.3

3.27 (0.96–11.19)

0.058

3.13 (0.92–10.64)

0.068

Ever experienced condom tearing during anal sex

 No

218

17.4

1

   

12.0

1

   

4.6

1

   

 Yes

106

27.8

1.81 (1.04–3.16)

0.035

2.37 (1.21–4.67)

0.012

09.2

0.74 (0.34–1.61)

0.454

–

–

2.9

0.61 (0.16–2.29)

0.467

–

 

Condom use at last anal sex with a regular male partner

 No

54

29.9

1

   

05.6

1

   

9.3

1

   

 Yes

240

16.6

0.46 (0.23–0.92)

0.029

0.41 (0.18–0.93)

0.033

11.2

2.13 (0.61–7.36)

0.230

–

–

2.1

0.21 (0.06–0.75)

0.017

0.24 (0.03–1.77)

0.163

Condom use at last anal sex with a casual male partner

 No

34

17.9

1

   

11.8

1

   

8.9

1

   

 Yes

224

19.2

1.09 (0.42–2.81)

0.857

–

 

10.3

0.86 (0.27–2.68)

0.795

–

–

3.6

0.38 (0.05–1.53)

0.175

0.50 (0.08–3.10)

0.456

HIV status

 Positive

10

40.0

1

   

11.0

1

   

0.0

–

   

 Negative

319

20.1

0.37 (0.10–1.38)

0.141

0.35 (0.06–1.85)

0.218

10.0

1.10 (0.13–9.11)

0.923

–

–

4.1

–

–

–

–

Ever injected drugs

 No

323

20.5

1

   

11.2

    

3.8

1

–

–

–

 Yes

6

16.7

0.78 (0.08–6.83)

0.819

–

 

0.0

–

–

–

 

16.7

5.11 (0.55–47.77)

0.152

7.19 (1.12–46.25)

0.038

  1. aRDS Respondent driven sampling
  2. bHBV Hepatitis B virus
  3. cHCV Hepatitis C virus
  4. dHTLV Human T-cell leukemia virus
  5. eOR Odds ratio
  6. fCI Confidence interval
  7. gAOR Adjusted odds ratio